Rivaroxaban and the EINSTEIN clinical trial programme

Rivaroxaban, a direct oral anticoagulant, is widely used for the treatment of venous thromboembolism (VTE) in adult patients. The approval of rivaroxaban for the treatment of deep vein thrombosis and pulmonary embolism and the extended secondary prevention of recurrent VTE is based on the results of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Alexander T., Bauersachs, Rupert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2019
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504120/
https://www.ncbi.nlm.nih.gov/pubmed/30920394
http://dx.doi.org/10.1097/MBC.0000000000000800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504120/
https://www.ncbi.nlm.nih.gov/pubmed/30920394
http://dx.doi.org/10.1097/MBC.0000000000000800

Ejemplares similares